Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,138.40
+11.00 (0.52%)
Sep 3, 2025, 9:30 AM IST
Caplin Point Laboratories Company Description
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion.
It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals.
Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Caplin Point Laboratories Limited
| Country | India |
| Founded | 1990 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,406 |
| CEO | Sridhar Ganesan |
Contact Details
Address: Ashvich Tower Chennai, 600096 India | |
| Phone | 91 44 2496 8000 |
| Website | caplinpoint.net |
Stock Details
| Ticker Symbol | CAPLIPOINT |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE475E01026 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sridhar Ganesan | MD and Whole Time Director |
| D. Muralidharan | Chief Financial Officer |
| Partheeban Vivek Siddarth | Chief Operating officer |
| G. Venkatram | General Counsel, Company Secretary and Compliance Officer |
| M. Sathya Narayanan | Deputy Chief Financial Officer |
| Ashok Gorekey Partheeban | Head of Marketing - Latam Business |